查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613031

全球可卡因使用障碍市场（依治疗方法、药物、治疗环境、产业）：未来预测（2025-2030）

Cocaine Use Disorder Market by Therapeutic Approaches (Behavioral Therapies, Cognitive-Behavioral Therapy, Contingency Management), Medications (Anticonvulsants, Antidepressants, Antipsychotics), Treatment Setting - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023 年可卡因使用障碍市值为 13.2 亿美元，预计到 2024 年将达到 13.9 亿美元，复合年增长率为 6.21%，到 2030 年将达到 20.1 亿美元。

可卡因使用障碍（CUD）是一个重大的公共卫生问题，其特征是强迫性使用可卡因，导致临床上严重的损害和痛苦。 CUD的范围主要涉及製药公司、研究机构、医疗保健提供者和復健中心，以开发针对CUD的治疗方法和疗法。解决 CUD 问题的必要性在于其高昂的社会成本，包括医疗成本、生产力损失和法律影响。因此，需要综合应用，包括药物辅助治疗、行为疗法以及包括遗传和神经生物学研究在内的创新方法。最终用途主要包括医院、復健设施，甚至旨在扩大受影响人群范围的推广远端医疗平台。

主要市场统计
基准年[2023] 13.2亿美元
预计年份 [2024] 13.9亿美元
预测年份 [2030] 20.1亿美元
复合年增长率（%） 6.21%

市场成长要素包括对药物滥用障碍认识的提高、医疗基础设施的加强以及对新治疗方法的持续研究。 CUD 日益增加的社会负担，加上不断进步的健康政策，正在推动对更有效干预策略的需求。数位健康技术和人工智慧主导的个人化治疗计划的整合凸显了该市场的治疗机会。公司可以投资行动应用程式来监控和促进患者的依从性，以及用于早期检测和预防策略的人工智慧工具。然而，严格的法律规范、围绕成瘾的社会耻辱以及复杂的行为健康变数导致的临床试验挑战等限制因素可能会阻碍市场成长。

该市场提供了强大的创新途径，包括探索神经调节技术和开发针对可卡因成瘾的特定大脑通路的非成瘾治疗方法。此外，与高科技公司的跨行业合作，特别是那些专注于人工智慧和机器学习的公司，可以加强研发倡议。透过持续创新和跨学科伙伴关係，将开发巨大的潜力，旨在治疗和理解可卡因成瘾的多方面方面。将此倡议扩展到全球伙伴关係还可以减少地区差异并加速市场成熟。

市场动态：揭示快速发展的可卡因使用障碍市场的关键市场洞察

可卡因使用障碍市场正因供需的动态互动而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 可卡因使用的全球流行
    • 提高对需要治疗可卡因使用障碍的成瘾问题的认识和社会接受度
    • 政府和私人资助成瘾治疗项目
  • 市场限制因素
    • 专业医疗保健提供者的数量有限以及与可卡因成瘾相关的社会耻辱
  • 市场机会
    • 使用利用遗传和心理社会标记的创新医疗方法进行个人化治疗
    • 人工智慧和机器学习在预测治疗结果和透过数位平台增强病人参与的应用
  • 市场挑战
    • 世界各地人群治疗效果的监管障碍与差异

波特的五力：驾驭可卡因使用障碍市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解可卡因使用障碍市场的外部影响

外部宏观环境因素在塑造可卡因使用障碍市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解可卡因使用障碍市场的竞争格局

可卡因使用障碍市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：可卡因使用障碍市场的供应商绩效评估

FPNV 定位矩阵是评估古柯碱使用障碍市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製可卡因使用障碍市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对可卡因使用障碍市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估市场范围和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析最近的产品发布、开拓的地区、关键产业进展以及塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1. 目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3. 塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 哪些收益来源和策略机会推动供应商的进入/退出策略？

目录

第一章简介

第二章 分析方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地可卡因使用量增加
      • 提高对成瘾问题的认识和社会接受度以及治疗可卡因使用障碍的需要
      • 为成瘾治疗计画提供公共和私人资金
    • 抑制因素
      • 缺乏专业的医疗保健提供者以及与可卡因成瘾相关的社会耻辱
    • 机会
      • 一种创新的医疗方法，利用遗传和心理社会标记来提供个人化治疗。
      • 应用人工智慧和机器学习来预测治疗结果并透过数位平台增强患者参与度
    • 任务
      • 世界各地人群的监管障碍和治疗效果差异
  • 市场区隔分析
    • 治疗环境：对住宅復健设施的兴趣日益浓厚
    • 药物：治疗可卡因使用障碍时对精神兴奋剂的基于需求的偏好
  • 波特五力分析
  • PESTEL分析
    • 政治因素
    • 经济因素
    • 社会因素
    • 技术因素
    • 法律因素
    • 环境因素

第六章 可卡因使用疾患的市场治疗：依治疗方法

  • 行为疗法
  • 认知行为疗法
  • 紧急管理
  • 药物治疗
  • 增加动力

第七章 可卡因使用疾患市场：依药物分类

  • 抗惊厥药
  • 抗忧郁症
  • 抗精神病药
  • 精神兴奋剂

第八章可卡因使用障碍市场：依治疗环境

  • 医院治疗计划
  • 住院復健中心
  • 日间復健中心
  • 居家復健设施

第九章美洲可卡因使用障碍市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

    第十章亚太地区可卡因使用疾患市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的可卡因使用疾患市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 市场占有率分析（2023）
  • FPNV定位矩阵（2023）
  • 竞争情境分析
    • 科学家研发出古柯碱疫苗
    • FDA核准新的Buprenornhine治疗鸦片类药物使用障碍
  • 战略分析和建议

公司名单

  • Alkermes PLC
  • Alnylam Pharmaceuticals, Inc.
  • Camurus AB
  • Indivior PLC
  • Johnson & Johnson Services, Inc.
  • KemPharm, Inc.
  • Novartis International AG
  • Orexo AB
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Revive Therapeutics Ltd.
  • Sage Therapeutics, Inc.
  • Shionogi & Co., Ltd.
  • Teva Pharmaceuticals USA, Inc.
  • Viatris Inc.
Product Code: MRR-F97DD5A7E128

The Cocaine Use Disorder Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.39 billion in 2024, and is projected to grow at a CAGR of 6.21%, to USD 2.01 billion by 2030.

Cocaine Use Disorder (CUD) is a significant public health issue characterized by the compulsive use of cocaine, leading to clinically significant impairment or distress. Its market scope primarily involves pharmaceutical companies, research institutions, healthcare providers, and rehabilitation centers developing treatments and therapies targeted at CUD. The necessity of addressing CUD is underscored by its high societal costs, ranging from healthcare expenses to lost productivity and legal implications. This calls for comprehensive applications, such as medication-assisted treatments, behavioral therapies, and innovative approaches involving genetic and neurobiological research. End-use primarily spans hospitals, rehabilitation facilities, and even telemedicine platforms aiming to expand outreach for affected individuals.

KEY MARKET STATISTICS
Base Year [2023] USD 1.32 billion
Estimated Year [2024] USD 1.39 billion
Forecast Year [2030] USD 2.01 billion
CAGR (%) 6.21%

Market growth factors include increasing awareness about substance use disorders, enhanced healthcare infrastructure, and ongoing research into novel treatment methodologies. The rising societal burden of CUD, combined with progressive healthcare policies, propels the demand for more effective intervention strategies. Opportunities in this market are highlighted by the integration of digital health technologies and AI-driven personalized treatment plans. Companies could invest in mobile applications for monitoring and encouraging patient adherence or AI tools for early detection and prevention strategies. However, limitations such as stringent regulatory frameworks, the social stigma surrounding addiction, and challenges in clinical trials due to complex behavioral health variables may impede market growth.

The market offers prime avenues for innovation, including the exploration of neuromodulation techniques and the development of non-addictive therapeutics that target specific brain pathways involved in cocaine addiction. Furthermore, cross-industry collaborations, especially with tech firms focusing on AI and machine learning, could bolster research and development initiatives. The nature of the market is one of cautious optimism, with considerable potential harnessed through sustained innovation and multi-disciplinary partnerships aimed at both treating and understanding the multifaceted aspects of cocaine addiction. Expanding initiatives to include global partnerships can also alleviate regional disparities and accelerate market maturity.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cocaine Use Disorder Market

The Cocaine Use Disorder Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of cocaine use worldwide
    • Increasing awareness and social acceptance of addiction issues, necessitating the treatments for cocaine use disorders
    • Governmental and private funding for addiction treatment programs
  • Market Restraints
    • Limited availability of specialized healthcare providers and social stigmas associated with cocaine addiction
  • Market Opportunities
    • Innovative medicine approaches utilizing genetic and psychosocial markers to tailor personalized treatments
    • Application of artificial intelligence and machine learning in predicting treatment outcomes and enhancements in patient engagement through digital platforms
  • Market Challenges
    • Regulatory hurdles and variability in treatment effectiveness across populations worldwide

Porter's Five Forces: A Strategic Tool for Navigating the Cocaine Use Disorder Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cocaine Use Disorder Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cocaine Use Disorder Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cocaine Use Disorder Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cocaine Use Disorder Market

A detailed market share analysis in the Cocaine Use Disorder Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cocaine Use Disorder Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cocaine Use Disorder Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cocaine Use Disorder Market

A strategic analysis of the Cocaine Use Disorder Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cocaine Use Disorder Market, highlighting leading vendors and their innovative profiles. These include Alkermes PLC, Alnylam Pharmaceuticals, Inc., Camurus AB, Indivior PLC, Johnson & Johnson Services, Inc., KemPharm, Inc., Novartis International AG, Orexo AB, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Revive Therapeutics Ltd., Sage Therapeutics, Inc., Shionogi & Co., Ltd., Teva Pharmaceuticals USA, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Cocaine Use Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Therapeutic Approaches, market is studied across Behavioral Therapies, Cognitive-Behavioral Therapy, Contingency Management, Medication-Assisted Treatment, and Motivational Enhancement.
  • Based on Medications, market is studied across Anticonvulsants, Antidepressants, Antipsychotics, and Psychostimulants.
  • Based on Treatment Setting, market is studied across Hospital-Based Treatment Programs, Inpatient Rehabilitation Centers, Outpatient Rehabilitation Centers, and Residential Rehabilitation Facilities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cocaine use worldwide
      • 5.1.1.2. Increasing awareness and social acceptance of addiction issues, necessitating the treatments for cocaine use disorders
      • 5.1.1.3. Governmental and private funding for addiction treatment programs
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of specialized healthcare providers and social stigmas associated with cocaine addiction
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative medicine approaches utilizing genetic and psychosocial markers to tailor personalized treatments
      • 5.1.3.2. Application of artificial intelligence and machine learning in predicting treatment outcomes and enhancements in patient engagement through digital platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and variability in treatment effectiveness across populations worldwide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment Setting: Increasing preference for residential rehabilitation facilities
    • 5.2.2. Medications: Need based preference for psychostimulants for treatment of cocaine use disorder
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cocaine Use Disorder Market, by Therapeutic Approaches

  • 6.1. Introduction
  • 6.2. Behavioral Therapies
  • 6.3. Cognitive-Behavioral Therapy
  • 6.4. Contingency Management
  • 6.5. Medication-Assisted Treatment
  • 6.6. Motivational Enhancement

7. Cocaine Use Disorder Market, by Medications

  • 7.1. Introduction
  • 7.2. Anticonvulsants
  • 7.3. Antidepressants
  • 7.4. Antipsychotics
  • 7.5. Psychostimulants

8. Cocaine Use Disorder Market, by Treatment Setting

  • 8.1. Introduction
  • 8.2. Hospital-Based Treatment Programs
  • 8.3. Inpatient Rehabilitation Centers
  • 8.4. Outpatient Rehabilitation Centers
  • 8.5. Residential Rehabilitation Facilities

9. Americas Cocaine Use Disorder Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cocaine Use Disorder Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cocaine Use Disorder Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Scientists Develop a Vaccine For Cocaine
    • 12.3.2. FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alkermes PLC
  • 2. Alnylam Pharmaceuticals, Inc.
  • 3. Camurus AB
  • 4. Indivior PLC
  • 5. Johnson & Johnson Services, Inc.
  • 6. KemPharm, Inc.
  • 7. Novartis International AG
  • 8. Orexo AB
  • 9. Otsuka Pharmaceutical Co., Ltd.
  • 10. Pfizer Inc.
  • 11. Revive Therapeutics Ltd.
  • 12. Sage Therapeutics, Inc.
  • 13. Shionogi & Co., Ltd.
  • 14. Teva Pharmaceuticals USA, Inc.
  • 15. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. COCAINE USE DISORDER MARKET RESEARCH PROCESS
  • FIGURE 2. COCAINE USE DISORDER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COCAINE USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. COCAINE USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. COCAINE USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COCAINE USE DISORDER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COCAINE USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COCAINE USE DISORDER MARKET DYNAMICS
  • TABLE 7. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COGNITIVE-BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY CONTINGENCY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATION-ASSISTED TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIPSYCHOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY PSYCHOSTIMULANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY HOSPITAL-BASED TREATMENT PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY INPATIENT REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY RESIDENTIAL REHABILITATION FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2030 (USD MILLION)
  • TABLE 150. COCAINE USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. COCAINE USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023